Litigation

The AHA, 340B Health, the Minnesota Hospital Association and American Society of Health-system Pharmacists Oct. 4 filed an amicus brief in the U.S. District Court for the District of Minnesota, defending the state's law protecting 340B pricing for contract pharmacy arrangements.
The AHA filed an amicus brief Oct. 4 in the U.S. Court of Appeals for the 5th Circuit challenging a decision by the U.S. District Court for the Northern District of Texas, which ruled that independent dispute resolution awards under the No Surprises Act are judicially unenforceable.
Amicus Brief: ABBVIE INC., et al., v. Keith M. Ellison, in his official capacity as Attorney General of Minnesota Motion to Dismiss 340B Litigation
A Louisiana district court Sept. 30 upheld a state law prohibiting drug companies from denying Louisiana hospitals 340B discounts for drugs dispensed at community pharmacies.
The AHA Sept. 9 released a report highlighting how hospitals’ arrangements with community and specialty pharmacies improve access to care for underserved patients.
A district court in Baltimore Sept. 5 ruled against drug companies and PhRMA, denying their attempt to obtain a preliminary injunction against 340B pricing for contract pharmacy arrangements in Maryland, according to Reuters.
The AHA, 340B Health and the American Society of Health-System Pharmacists last week filed an amicus brief in a federal district court in Missouri, defending the state's law protecting 340B pricing for contract pharmacy arrangements.
If Johnson & Johnson moves forward with its plan to undermine the 340B Drug Pricing Program by unilaterally imposing a rebate model rather than the longstanding upfront discount model, the Health Resources and Services Administration should take “immediate enforcement action,” including…